
Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: April 2009
-
By Kevin E. Noonan — Senator Leahy (D-VT) (at right), chairman of the Senate Judiciary Committee, has circulated several amendments to be proposed to reflect the "compromise" he hopes to have reached with Senators Specter (R-PA) and Feinstein (D-CA) over S. 515, his "patent reform" bill. While there are several minor amendments among them,…
-
By Donald Zuhn — Last Thursday, Senator Charles Schumer (D-NY) (at right) introduced the Promoting Innovation and Access to Life-Saving Medicine Act (S. 726), the first follow-on biologics bill to be introduced in the Senate and third follow-on biologics bill to be introduced in the 111th Congress. The new bill is the Senate companion…